Jeremy M. Levin, former President and CEO, Teva Pharmaceutical Industries

Global Markets and Local Companies

March 14, 2014 | 12:00pm - 1:30pm | Baker Library | Bloomberg Center 102

Organizer

Technology & Operations Management Unit

All Seminars and
Conferences »

A light lunch will be provided for those who RSVP.

To RSVP or for questions on a seminar or to join the mailing list or arrange parking, please contact sbbi@hbs.edu.

BIO: Until recently, Dr. Levin was the President and CEO of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, a global pharmaceutical company with 47,000 employees , operations in over 70 countries and over $20 Bn in revenue).  He is a physician and scientist by training and has worked in the pharmaceutical industry for more than 25 years. He is deeply interested in discovery, development and commercialization of novel medicines, global markets, development of modern sustainable companies and the intersection of digital technologies with the healthcare and pharmaceutical industries worldwide.
Prior to joining Teva, Dr. Levin served on the executive committee of Bristol-Myers Squibb (BMS) and had global responsibilities for strategy, alliances and all transactions. In this position he was responsible for the String of Pearls strategy to rebuild the companys pipeline and product capabilities. He previously held the position of Global Head of Strategic Alliances at Novartis Institutes of Biomedical Research. In this role, he was the strategic point of contact for worldwide alliances with academia and biotechnology, and also established multiple strategic collaborations.  Prior to Novartis Dr. Levin was the CEO of several public and private biotechnology companies.
Dr. Levin is the recipient of numerous awards and Prizes. During his academic career at Cambridge University he was the recipient of the Kermode Prize for work on novel hypertension drugs.  More recently Dr. Levin was awarded the Albert Einstein Award for Leadership in Life Sciences and in 2012, FierceBiotech voted him as one of the 25 most influential people in the biopharmaceutical industry. In 2013, Bnai Brith awarded him the Award for Distinguished Achievement and Dr Levin was awarded the Officer's Cross of the Order of Merit of the Republic of Hungary.
Dr. Levin holds a BA Hons (First Class) and MA, as well as a D. Phil in Cell Biology and Chromatin Structure, from the University of Oxford. He completed his medical and surgical training at the University of Cambridge and is a practicing Physician.